BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24821909)

  • 1. A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
    Ahn HJ; Glickman JF; Poon KL; Zamolodchikov D; Jno-Charles OC; Norris EH; Strickland S
    J Exp Med; 2014 Jun; 211(6):1049-62. PubMed ID: 24821909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.
    Flemming A
    Nat Rev Drug Discov; 2014 Jul; 13(7):494. PubMed ID: 24948119
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
    Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S
    Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.
    Singh PK; Kawasaki M; Berk-Rauch HE; Nishida G; Yamasaki T; Foley MA; Norris EH; Strickland S; Aso K; Ahn HJ
    Biochemistry; 2018 Feb; 57(8):1399-1409. PubMed ID: 29394041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
    Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
    Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.
    Ahn HJ; Zamolodchikov D; Cortes-Canteli M; Norris EH; Glickman JF; Strickland S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21812-7. PubMed ID: 21098282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
    Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
    J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecanemab blocks the effects of the Aβ/fibrinogen complex on blood clots and synapse toxicity in organotypic culture.
    Singh PK; Simões-Pires EN; Chen ZL; Torrente D; Calvano M; Sharma A; Strickland S; Norris EH
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2314450121. PubMed ID: 38621133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen and altered hemostasis in Alzheimer's disease.
    Cortes-Canteli M; Zamolodchikov D; Ahn HJ; Strickland S; Norris EH
    J Alzheimers Dis; 2012; 32(3):599-608. PubMed ID: 22869464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
    Cao C; Cirrito JR; Lin X; Wang L; Verges DK; Dickson A; Mamcarz M; Zhang C; Mori T; Arendash GW; Holtzman DM; Potter H
    J Alzheimers Dis; 2009; 17(3):681-97. PubMed ID: 19581723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.
    Mori T; Rezai-Zadeh K; Koyama N; Arendash GW; Yamaguchi H; Kakuda N; Horikoshi-Sakuraba Y; Tan J; Town T
    J Biol Chem; 2012 Feb; 287(9):6912-27. PubMed ID: 22219198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.
    Huang Y; Guo B; Shi B; Gao Q; Zhou Q
    J Alzheimers Dis; 2018; 63(3):1089-1107. PubMed ID: 29710701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.